← SynDRA
SYN1307379
SynDRA canonical compound SYN1307379 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | TNKS | TNKS2 |
|---|
| Mechanism of action | tankyrase inhibitor |
|---|
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- G007-LK
- MFCD28167833
- C25H16ClN7O3S
- 4hyf
- HIWVLHPKZNBSBE-OUKQBFOZSA-N
- orb1300415
- SCHEMBL9904844
- SCHEMBL29372843
- EX-A656
- GLXC-03333
- G-007-LK
- BDBM50427989
- s7239
- AKOS030526468
- CCG-269912
- NCGC00390587-01
- NCGC00390587-03
- NCGC00390587-05
- AC-33045
- AS-75199
- DA-73602
- SY128971
- T6842
- F865636
- A1-02247
- BRD-K12198961-001-01-8
- 1AK
- 4-{5-[(E)-2-{4-(2-chlorophenyl)-5-[5-(methylsulfonyl)pyridin-2-yl]-4H-1,2,4-triazol-3-yl}ethenyl]-1,3,4-oxadiazol-2-yl}benzonitrile
Look up SYN1307379 in the interactive SynDRA portal →